Skip to content

Effects of hot pack and ice pack intervention and electrical intervention on sensation and movement ability of the arm and hand in individuals with acute stroke

Comparison of the effects of thermal stimulation and transcutaneous electrical nerve stimulation on upper extremity sensory and motor function in individuals with acute stroke: a randomized controlled pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN62945682
Enrollment
30
Registered
2022-05-25
Start date
2015-01-28
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intervention for individuals with acute stroke Nervous System Diseases

Interventions

Participants in this study will be allocated into thermal stimulation group, transcutenous electrical nerve stimulation group, and the control group by sealed envelope. For thermal stimulation (TS) g

Sponsors

Kaohsiung Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 20 years or older 2. Have a stroke for the first time 3. Have been examined by a physician, and were approved to receive rehabilitation treatment 4. Hospitalized during the acute phase 5. Hemiparesis 6. Do not have obvious cognitive impairments 7. Can independently maintain a sitting posture for at least 30 min

Exclusion criteria

Exclusion criteria: 1. Have skin conditions or injuries (e.g., wounds) on upper limbs or have other contraindications for electrotherapy or TS (e.g., a malignant tumor) 2. Have a language disorder (e.g., aphasia) and is therefore unable to communicate or comply with instructions 3. Have other orthopedic conditions (e.g., severe arthritis) or nerve damage (e.g., peripheral nerve injury) affecting movement in their upper limbs 4. Have diabetes or complete sensory impairment not caused by stroke (e.g., peripheral vascular disease or neuropathy) 5. Have developed neurological disorders during the experiment period or other conditions that may affect the study results 6. Have uncontrolled hypertension, unstable angina, a history of myocardial infarction or epilepsy (excepting febrile seizures) in the past 3 months, or a pacemaker 7. Have participated in other rehabilitation trials or drug trials 8. Unable to cooperate with the researchers because of cognitive or personal reasons or refused to provide written informed consent

Design outcomes

Primary

MeasureTime frame
Measured at baseline (before intervention) and after 5 days (after completing intervention): 1. Motor recovery is measured using Fugl-meyer upper extremity scale assessment 2. Motor function recovery is measured by Brunnstrom stage assessment 3. Sensory is measured by minimal current perception

Secondary

MeasureTime frame
Measured at baseline (before intervention) and after 5 days (after completing intervention): The spasticity of upper limb is measured by Modified ashworth scale assessment

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026